Previous Article | Next Article ![]()
Journal of Virology, October 2001, p. 9771-9779, Vol. 75, No. 20
Partners AIDS Research Center and Infectious Disease Unit,
Massachusetts General Hospital and Harvard Medical School, Boston,
Massachusetts 021141; Department of
Microbiology and Immunology and Kimmel Cancer Institute, Thomas
Jefferson University, Philadelphia, Pennsylvania
191072; and Fenway Community Health
Center, Boston, Massachusetts 021153
Received 13 April 2001/Accepted 6 July 2001
Mounting evidence suggests that human immunodeficiency virus type 1 (HIV-1) Gag-specific T helper cells contribute to effective antiviral
control, but their functional characteristics and the precise epitopes
targeted by this response remain to be defined. In this study, we
generated CD4+ T-cell clones specific for Gag from
HIV-1-infected persons with vigorous Gag-specific responses detectable
in peripheral blood mononuclear cells. Multiple peptides containing T
helper epitopes were identified, including a minimal peptide, VHAGPIAG
(amino acids 218 to 226), in the cyclophilin binding domain of Gag.
Peptide recognition by all clones examined induced cell proliferation, gamma interferon (IFN-
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.20.9771-9779.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Multiple Effector Functions Mediated by Human
Immunodeficiency Virus-Specific CD4+ T-Cell
Clones
) secretion, and cytolytic activity. Cytolysis was abrogated by concanamycin A and EGTA but not brefeldin A or anti-Fas antibody, implying a perforin-mediated mechanism of cell lysis. Additionally, serine esterase release into the extracellular medium, a marker for cytolytic granules, was demonstrated in an antigen-specific, dose-dependent fashion. These data indicate that T
helper cells can target multiple regions of the p24 Gag protein and
suggest that cytolytic activity may be a component of the antiviral
effect of these cells.
*
Corresponding author. Mailing address: Massachusetts
General Hospital, GRJ 504, 55 Fruit St., Boston, MA 02114. Phone: (617) 724-7519. Fax: (617) 726-7416. E-mail:
erosenberg1{at}partners.org.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|